Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2017.6407 mmr-15-05-3147 Articles Extravasated platelet aggregation in the livers of rats with drug-induced hepatic sinusoidal obstruction syndrome HirataMiki 1 TajimaHidehiro 1 MiyashitaTomoharu 1 MiyataTakashi 1 NakanumaShinichi 1 MakinoIsamu 1 HayashiHironori 1 OyamaKatsunobu 1 TakamuraHiroyuki 1 NinomiyaItasu 1 FushidaSachio 1 NakataHiroki 2 IsekiShoichi 2 HaradaShinichi 3 WakayamaTomohiko 4 OhtaTetsuo 1 Department of Gastroenterological Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan Department of Histology and Embryology, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan Center of Biochemical Research, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan Department of Histology, Faculty of Life Sciences, Kumamoto University, Kanazawa, Ishikawa 920-8641, Japan Correspondence to: Dr Hidehiro Tajima, Department of Gastro-enterological Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan, E-mail: hidetaji@staff.kanazawa-u.ac.jp 052017 28032017 15 5 3147 3152 07062016 13032017 Copyright © 2017, Spandidos Publications 2017

Oxaliplatin-based chemotherapy plays an important role in the treatment of colorectal liver metastases. Oxaliplatin, however, causes sinusoidal obstruction syndrome (SOS), which is characterized by portal hypertension, splenomegaly, thrombocytopenia, and liver dysfunction. SOS is diagnosed histopathologically by disruption of the sinusoidal endothelium, collagen deposition, fibrosis especially around zone 3, dilatation of the sinusoidal space and congestion. This study assessed the characteristics of a rat model of SOS. SOS was induced in rats by administration of monocrotaline (MCT). Blood chemistries and macroscopic and microscopic findings were compared in rats administered MCT and vehicle (control group). Levels of expression in the liver of CD41, P-selectin, rat endothelial cell antigen-1, CD34, and cleaved caspase-3 were analyzed immunohistochemically. Moreover, livers of these rats were analyzed by electron microscopy. Macroscopically, MCT-treated rats showed accumulation of bloody ascites and blue liver and were diagnosed with SOS histologically. Serum concentrations of aspartate aminotransferase (P=0.003), alanine aminotransferase (P=0.008), total-bilirubin (P=0.012), direct-bilirubin (P=0.007), indirect-bilirubin (P=0.003), lactate dehydrogenase (P<0.001) and hyaluronic acid (P=0.016) were significantly higher, and platelet counts significantly lower (P=0.004), in MCT-treated than in control rats. The livers of MCT-treated rats were immunohistochemically positive for CD41 and P-selectin, suggesting platelet aggregates; for rat endothelial cell antigen-1 and CD34, suggesting sinusoidal endothelial disorder; and for cleaved caspase-3, suggesting hepatocyte apoptosis. Electron microscopic findings revealed platelet aggregation in the space of Disse in the MCT group. Extravasated platelet aggregation in Disse's space may be involved in the development of SOS.

 extravasated platelet aggregation sinusoidal obstruction syndrome colorectal liver metastases zone 3 Introduction

Systemic neoadjuvant chemotherapy can precede conversion surgery, resulting in R0 resection, even in patients with initially unresectable colorectal liver metastases (CRLM). Although oxaliplatin-based chemotherapy plays a central role in the treatment of patients with CRLM, oxaliplatin can induce sinusoidal obstruction syndrome (SOS), which is characterized by hepatic sinusoidal dilatation, hepatocyte atrophy, peri-sinusoidal fibrosis, and nodular regenerative hyperplasia (1). These histological changes have been reported in up to 40% of patients treated with oxaliplatin-based regimens undergoing liver resection (2–6). SOS prior to major hepatectomy has been associated with increased peri-operative morbidity and prolonged hospital stay (7). Clinically, factors diagnostic of SOS include portal hypertension, splenomegaly, thrombocytopenia, an abnormal indocyanine green (ICG) retention rate and elevated liver enzymes, bilirubin and hyaluronic acid (HA) (8–12). On pathological examination, SOS is characterized by the disruption of the sinusoidal endothelium, collagen deposition in peri-sinusoidal spaces, fibrosis especially around the central vein (in zone 3), dilatation of the sinusoidal space and congestion (13). Platelets were shown to be involved in the alterations in the sinusoidal endothelium observed in patients with SOS (14). Thrombocytopenia has been observed in patients with CRLM treated with oxaliplatin based chemotherapy, and examination of their resected livers showed platelet aggregation in zone 3 (15). Platelet aggregation in the extra-sinusoidal (Disse's) space is called extravasated platelet aggregation (EPA). This study assessed whether EPA was present in the livers of rats with drug induced SOS.

 Materials and methods <sec> <title>Reagents

Monocrotaline (MCT) was purchased from Wako Pure Chemical Industries (Osaka, Japan). A 20 mg/ml solution of MCT was prepared by dissolving 1,000 mg MCT in 1.0 N HCl, and adjusting the pH to 7.4 with 0.5 N NaOH, followed by dilution in phosphate-buffered saline (PBS), pH 7.4, to increase the total volume to 50 ml (16,17).

 Animals

Male Wistar rats, weighing 230–300 g, were purchased from Charles River Inc. (Kanagawa, Japan), and allowed free access to water and standard laboratory chow. This study complied with the guidelines of the Division for Animal Research Resources, University of Kanazawa. All experiments and procedures were approved by the Animal Care and Use Committee of the University of Kanazawa.

 Experimental protocol

The animals were randomly divided into two groups of 10 rats each. Animals were fasted for 12 h, with one group administered MCT (90 mg/kg) and the control group administered water (Fig. 1). Rats were thereafter allowed free access to water and standard laboratory chow ad libitum. Because histopathological changes 48 h after MCT administration are similar to those in patients with SOS, (16,18) the rats were anesthetized by inhalation of diethyl ether and sacrificed. Blood was collected from the inferior vena cava, and liver tissues were obtained.

 Macroscopic examination

The abdominal cavity of rats was accessed by middle incision laparotomy, and the effect of MCT assessed macroscopically by the accumulation of peritoneal fluid and the color of the liver surface.

 Biochemical analysis

Blood specimens were collected, and white blood cell (WBC) and platelet counts, as well as hemoglobin (Hb) concentrations, were measured using an automated blood cell counter (Celltac α, MEK-6458, Nihon Kohden, Japan). Serum concentrations of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (T-Bil), direct bilirubin (D-Bil), indirect bilirubin (I-Bil) lactate dehydrogenase (LDH) and hyaluronic acid (HA) were measured by SRL Inc. (Tokyo, Japan).

 Histologic analysis

Liver tissue was fixed in 10% neutral buffered formalin, embedded in paraffin, and cut serially into 4-µm sections. Slides were stained with hematoxylin and eosin (H&E), and ten randomly selected high-power fields (magnification, ×200) were examined. The degree of SOS was assessed by examining histological changes in sinusoidal dilatation, coagulative necrosis of hepatocytes, endothelial damage to the central vein, and sinusoidal hemorrhage (16,18,19). Each of these four features was graded on a 4-point scale, with 0, absent; 1, mild (1–30%); 2, moderate (31–60%); and 3, severe (61–100%). The total SOS score for each rat was calculated as the sum of the individual scores.

 Immunohistochemistry

Tissue samples were fixed in 4% paraformaldehyde in phosphate buffered saline for 3 days and embedded in a solution of O.C.T. compound (Sakura Finetek, Tokyo, Japan) and 30% sucrose in 0.1 M phosphate buffer, pH 7.4, containing 0.05% NaN3. All tissue samples were sectioned at 6 µm using cryostats (Thermo Fisher Scientific, Waltham, MA, USA).

Immunohistochemical staining was performed with the Dako Envision system (Dako, Carpinteria, CA, USA), which uses dextran polymers conjugated with horseradish peroxidase, thus avoiding contamination by endogenous biotin. Tissue samples were dissected out, immersed in fixative for 4 h, dehydrated in a graded alcohol series for 24 h, embedded in paraffin, and cut into 4-mm-thick sections. Endogenous peroxidases were blocked by immersing the sections in 3% H2O2 in 100% methanol for 20 min at room temperature. Antigen retrieval was performed by micro-waving sections at 95°C for 10 min in 0.001 M citrate buffer (pH 6.7). The sections were incubated with serum-free protein block (Dako) at room temperature for 10 min to block non-specific staining, followed by incubation for 2 h at room temperature with primary monoclonal antibody. Peroxidase activity was detected with the enzyme substrate 3-amino-9-ethyl carbazole. As negative controls, tissue sections were incubated with Tris-buffered saline without the primary antibodies. All samples were counterstained with Meyer's hematoxylin.

Platelet aggregation was assessed by immunohistochemical staining of liver tissues with antibodies to platelet glycoprotein IIb (CD41) (1:100, orb4832; Biorbyt, Cambridge, UK) and P-selectin (1:50, ERP1444(2)(B); Abcam, Tokyo, Japan), the latter being a member of the selectin family of adhesion molecules expressed on activated platelets and endothelium (20). Damage to sinusoidal endothelial cells was determined by immunostaining rat liver tissues with antibodies to rat endothelial cell antigen-1 (RECA-1) (#MCZ-970R; Serotec, Oxford, UK) and CD34 (1:20, AF4117; R&D Systems, Inc., Minneapolis, MN, USA), the latter being a marker of sinusoidal capillary formation in liver tissue, thereby differentiating between normal and altered sinusoidal epithelium (21–24). Hepatocyte apoptosis was determined by immunostaining with antibody to cleaved caspase-3 (1:100, 9661; Cell Signaling Technology, Inc., Beverly, MA, USA). Dyeabilities of these factors were measured with the BZ-Analyzer software (Keyence, Osaka, Japan). The total stained areas were calculated from randomly selected images per high power field (magnification, ×200) and compared between the two groups.

 Transmission electron microscopy

Rat liver specimens were fixed by immersion in 2% paraformaldehyde plus 2.5% glutaraldehyde in phosphate buffer (pH 7.4) for 4 h at 4°C. After washing in phosphate buffer at 4°C, the specimens were postfixed in 1% osmium tetraoxide for 2 h at 4°C, washed repeatedly in distilled water, stained with 1% uranyl acetate for 30 min, dehydrated through a graded ethanol series and propylene oxide, and embedded in Glicidether (Selva Feinbiochemica, Heidelberg, Germany). Ultrathin sections were cut and mounted onto copper grids, stained with 1% uranyl acetate for 10 min and with Reynolds lead citrate for 5 min, and evaluated using an H7650 electron microscope (Hitachi, Tokyo, Japan) (25).

 Statistical analysis

All results were expressed as the mean ± standard deviation (SD). Groups were compared by Student's t-tests. P<0.05 was considered to indicate a statistically significant difference.

 Results

At sacrifice, macroscopic examination of the livers in the MCT group showed accumulation of bloody ascites, with the liver surface appearing congested and dark red in color (Fig. 1). These changes were not observed in the control group. The difference of liver size and weight was not observed between the two groups.

The results of complete blood counts and serum biochemistry tests are shown in Table I. There were no between group differences in WBC count and Hb concentration, although platelet counts were significantly lower in the MCT than in the control group (P=0.004). Serum concentrations of AST (P=0.003), ALT (P=0.008), T-Bil (P=0.012), D-Bil (P=0.007), I-Bil (P=0.003), LDH (P<0.001) and HA (P=0.0016) were all significantly higher in the MCT than in the control group.

Histologically, H&E staining of liver tissue showed higher SOS scores in the MCT than in the control group, with the former group showing all four histological changes: sinusoidal dilatation, coagulative necrosis of hepatocytes, endothelial damage to the central vein, and sinusoidal hemorrhage (Fig. 2).

CD41 protein expression was observed in the MCT group, especially in zone 3, but not in the control group (Fig. 3). Assessment of P-selectin expression showed that, in the control group, it was present only on the endothelial cells of the sinusoids (Fig. 4A). In the MCT group, however, P-selectin expression was observed on both sinusoidal endothelial cells and granularly stained platelets (Fig. 4B).

RECA-1 protein expression was markedly lower in the MCT (Fig. 5B) than in the control group (Fig. 5A), indicating that the sinusoidal lining had largely disappeared from the former. In contrast, CD34 expression was higher in the MCT group, especially in zone 3 (Fig. 6B), than in the control group (Fig. 6A). Similarly, cells positive for cleaved caspase-3 were observed in zone 3 in the MCT group 3 (Fig. 7B), but not in the control group. Measurements of the staining areas of MCT and control group are shown in Table II. In the MCT group, significant excessive staining was observed in all the factors in comparison with the control group.

Electron microscopic examination of the MCT group showed many platelets containing granules in the space of Disse (Fig. 8).

 Discussion

SOS is a veno-occlusive disease (VOD), characterized by hepatic injury after exposure to a drug or toxin or after bone marrow transplantation (26). SOS can present in acute, subacute and chronic forms, usually as abdominal pain and/or swelling, with evidence of portal hypertension and variable degrees of serum enzyme elevation and jaundice. Liver histology shows obstruction of the sinusoids in the central areas, along with hepatocyte necrosis and hemorrhage. Agents that cause SOS include cancer chemotherapeutic agents, particularly alkylating agents such as cyclophosphamide and the platinum coordination complexes cisplatin and oxaliplatin. The diagnosis of SOS usually depends on a typical clinical presentation, characterized by hepatomegaly, ascites, portal hypertension, weight gain and jaundice (27), or by the exclusion of other causes of liver injury. The usual differential diagnosis of SOS after bone marrow transplantation includes graft vs. host disease, sepsis, other forms of drug induced liver injury, and various forms of viral hepatitis. SOS diagnosis is usually supported by imaging modalities that demonstrate changes typical of sinusoidal obstruction. Liver biopsy is diagnostic but is not usually needed; moreover, concurrent coagulopathy or thrombocytopenia make it difficult to acquire biopsy samples (28). Although thrombocytopenia in SOS usually results from hypersplenism, decreased platelet counts have been observed earlier than splenomegaly (15). Therefore, this research focused on the role of platelets in the pathogenesis of SOS.

Histologic examination of the liver in patients with SOS shows obstruction of the sinusoids around the central vein (zone 3), along with hepatocyte necrosis and congestion. SOS may be caused by cancer chemotherapeutic and immunosuppressing agents. SOS was shown to be induced by oxaliplatin based chemotherapy in patients with CRLM, appearing as blue liver. Administration of MCT to rats induced SOS, with the macroscopic appearance of blue liver and SOS detected histologically. Blood analysis showed that treatment with MCT significantly increased serum concentrations of AST, ALT, T-Bil, D-Bil and HA, with the latter reflecting injury to liver sinusoidal endothelial cells (LSECs) (13).

Histopathologically, administration of MCT resulted in sinusoidal dilatation, coagulative necrosis of hepatocytes, endothelial damage to the central vein, and sinusoidal hemorrhage. Immunohistochemical assays showed that MCT administration resulted in reduced RECA-1 and increased CD34 expression. Reduced RECA-1 expression indicated that the sinusoidal lining had largely disappeared. CD34 has been used to detect sinusoidal capillary formation in liver tissue and to differentiate between normal and altered sinusoidal epithelium (20–23).

Neutrophils and platelets participate in the pathogenesis of severe sepsis, as well as forming neutrophil extracellular trapping systems (NETs) to kill pathogens extracellularly (29). NETs, however, have been reported to contribute to organ damage in patients with infectious diseases (30) Furthermore, sivelestat sodium, a neutrophil elastase inhibitor, was found to inhibit neutrophil adhesion and migration to vascular endothelium during hepatic ischemia reperfusion and prevent liver injury (31). Platelets are not stained by H&E. because they lack nuclei. Platelets can be visualized in rats by immunostaining with antibody to the surface marker, CD41. Clinically, we observed EPA in SOS patients after liver transplantation (32,33) and after oxaliplatin chemotherapy (15). Platelets can be indirectly localized by detection of their surface markers. However, it was possible to directly verify the presence of platelets in the space of Disse around zone 3 by electron microscopy in the MCT group.

SOS has also been referred to as VOD in transplantation. Autopsy reports have shown that the pathology of human VOD includes reticulin deposition within sinusoids, central vein occlusion, hepatocyte atrophy/necrosis, sinusoidal hemorrhage, and sparing of portal tracts (34). Earlier histopathological findings of VOD can be detected by examining liver biopsy specimens. The affected venules show a lumen narrowed by a wide, edematous subendothelial zone containing a fibrous material and fragmented red cells. The sinusoids draining into these veins are congested, and the surrounding hepatocytes are pale and necrotic. Hemorrhage is also observed in the space of Disse.

Although sinusoidal fibrosis in zone 3 is regarded as an equivalent of early VOD, this diagnosis is not usually accepted unless there are significant changes in the central vein (35). Despite venous reflux disorder, with portal blood flowing back, being observed in patients with severe SOS, but venous obstruction or thrombosis has not been detected pathologically. Platelets not only form a white thrombus, but may cause spasms in the central vein by secreting various growth factors, including thromboxane A2 (TXA2), vascular endothelial growth factor (VEGF)-A, transforming growth factor (TGF)-β and plasminogen activator inhibitor (PAI)-1 (36). These growth factors can explain the liver injury in SOS. For example, TXA2 can cause central vein occlusion and portal hypertension, (37) and thrombospondin-activated TGF-β can cause collagen deposition in the peri-sinusoidal space and inhibit substance exchange in the space of Disse (28). TGF-β can also increase serum bilirubin concentration and may be responsible for an abnormal ICG retention rate. PAI-1 and TGF-β interfere with liver regeneration by suppressing hepatocyte growth factor (38). Although VEGF-A usually acts as a vasodilator, it can act as a vasoconstrictor under conditions of endothelial failure and hepatic sinusoidal injury (39). Platelet aggregation in the space of Disse may explain many of the symptoms, venous perfusion abnormalities, and portal hypertension detected in SOS, findings that cannot be confirmed pathologically. Thus, antiplatelet agents, including vasodilators such as prostaglandin E1 (40) and low dose heparin, (41) may prevent or reduce SOS.

In conclusion, EPA in the space of Disse has been confirmed in this rat model of MCT-induced liver SOS. Platelets are heavily involved in the development of SOS.

 References Rubbia-BarandtLAudardVSartorettiPRothADBrezaultCLe CharpentierMDoussetBMorelPSoubraneOChaussadeSSevere hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerAnn Oncol15460466200410.1093/annonc/mdh09514998849 HubertCFevailleCSempouxCHorsmansYHumbletYMachielsJPZechFCerattiAGigotJFPrevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastasesSurgery147185194201010.1016/j.surg.2009.01.00420109620 VautheyJNPawlikTMRiberoDWuTTZorziDHoffPMXiongHQEngCLauwersGYMino-KenudsonMChemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesJ Clin Oncol2420652072200610.1200/JCO.2005.05.307416648507 TamandlDKlingerMEipeldauerSHerbergerBKaczirekKGruenbergerBGruenbergerTSinusoid obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapyAnn Surg Oncol18421430201110.1245/s10434-010-1317-420844968 RobinsonSMWilsonCHBurtADManasDMWhiteSAChemotherapy associated liver injury in patients with colorectal liver metastases: A systemic review and meta-analysisAnn Surg Oncol1942874299201210.1245/s10434-012-2438-8227669813505531 AloysiusMMZaitounAMBeckinghamIJNealKRAithalGPBessellEMLoboDNThe pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: A comparative studyVirchows Arch451943948200710.1007/s00428-007-0497-117805566 NakanoHOussoultzoqlouERossoECasnediSChenard-NeuMPDufourPBachellierPJaeckDSinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapyAnn Surg247118124200810.1097/SLA.0b013e31815774de18156931 JardimDLRodoriguesCANovisYARochaVGHoffPMOxaliplatin-related thrombocytopeniaAnn Oncol2319371942201210.1093/annonc/mds07422534771 MiuraKNakanoHSakuraiJKobayashiSKoizumiSAraiTShimamuraTMakizumiRYamadaKMiyajimaNSplenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy- associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapyInt J Clin Oncol16257263201110.1007/s10147-010-0176-021243394 KliegerPMTamandlDHerbergerBFaybikPFleichmannEMareschJGruengergerTEvaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testingAnn Surg Oncol1816441650201110.1245/s10434-010-1494-121207168 SatoSNakanoHIshidaYOtsuboTThe aspartate aminotransferase to platelet ratio before chemotherapy predicts adverse events for FOLFOX and XELOX regimens including bevacizumab as the first-line therapy for stage IV, recurrent and metastatic colorectal cancerJ Gastrointest Oncol42032092013237305173635181 NaritaMOussoultzoglouEChenardMPFuchshuberPRatherMRossoEAddeoPJaeckDBachellierPLiver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarizationAnn Surg Oncol1922302237201210.1245/s10434-011-2112-622402811 MorineYShimadaMUtsunomiyaTEvaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasisHepatol Res445969201310.1111/hepr.1210723551330 LalorPFHerbertJBicknellRAdamsDHHepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leucocyte recruitmentAm J Physiol Gastrointest Liver Physiol304G469G478201310.1152/ajpgi.00407.201223257923 TajimaHOhtaTMiyashitaTNakanumaSMatobaMMiyataTSakaiSOkamotoKMakinoIKinoshitaJOxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liverMol Clinic Oncol35555582015 NaritaMHatanoEIkaiIMiyagawa-HayashinoAYanagidaANagataHAsechiHTauraKUemotoSA phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 inductionAnn Surg249806813200910.1097/SLA.0b013e3181a38ed519387321 PriéSStewartDJDupuisJEndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertensionCirculation9721692174199810.1161/01.CIR.97.21.21699626178 NakamuraKHatanoENaritaMMiyagawa-HayashinoAKoyamaYNagataHIwaisakoKTauraKUemotoSSorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9Hepatology5710371043201210.1016/j.jhep.2012.07.004 DeLeveLDMcCuskeyRSWangXHuLMcCuskeyMKEpsteinRBKanelGCCharacterization of a reproducible rat model of hepatic veno-occlusive diseaseHepatology2917791791199910.1002/hep.51029061510347121 SuzukiMBachelet-VioletteLRouzetFBeilvertAAutretGMaireMMenagerCLouedecLChoqueuxCSabouralPUltrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombusNanomedicine (Lond)107387201510.2217/nnm.14.5124960075 WisseEDe ZangerRBCharelsKVan Der SmissenPMcCuskeyRSThe liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of DisseHepatology5683692198510.1002/hep.18400504273926620 FinaLMolgaardHVRobertsonDBradleyNJMonaghanPDeliaDSutherlandDRBakerMAGreavesMFExpression of the CD34 gene in vascular endothelial cellsBlood752417242619901693532 CouvelardAScoazecJYDaugeMCBringuierAFPotetFFeldmannGStructural and functional differentiation of sinusoidal endothelial cells during liver organogenesis in humansBlood874568458019968639825 KuntzEKuntzHDTextbook and Atlas: History, Morphology, Biochemistry, Diagnostics, Clinic, TherapyHepatology3rdSpringer Medizin VerlagHeidelberg200810.1002/hep.22549 WakayamaTNakataHKuroboMSaiYIsekiSExpression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testisJ Histochem Cytochem57351362200910.1369/jhc.2008.952440190647152664978 JelliffeDBBrasGStuartKLVeno-occlusive disease of the liverPediatrics14334339195413204101 Campos-VarelaICastellsLDopazoCPérez-LafuenteMAllendeHLenOLlopartLVargasVCharcoRTransjuglar intrahepatic portsystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literatureLiver Transpl18201205201210.1002/lt.2235121656652 YaoLYaoZMYuTInfluence of BOL on hyaluronic acid, laminin and hyperplasia in hepatofibrotic ratsWorld J Gastroenterol7872875200110.3748/wjg.v7.i6.872118549204695613 BrinkmannVReichardUGoosmannCFaulerBUhlemannYWeissDSWeinrauchYZychlinskyANeutrophil extracellular traps kill bacteriaScience30315321535200110.1126/science.1092385 MerzaMHartmanHRahmanMHwaizRZhangERenströmELuoLMörgelinMRegnerSThorlaciusHNeutrophil extracellular traps induce trypsin activation, inflammation and tissue damage in mice with severe acute pancreatitisGastroenterology14919201931e8201510.1053/j.gastro.2015.08.02626302488 SakaiSTajimaHMiyashitaTNakanumaSMakinoIHayashiHNakagawaraHKitagawaHFushidaSFujimuraTSivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia reperfusion injuryDig Dig Sci59787794201410.1007/s10620-013-2963-8 NakanumaSMiyashitaTHayashiHTajimaHTakamuraHTsukadaTOkamotoKSakaiSMakinoIKinoshitaJExtravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case reportExp Therap Med9111911242015 TakamuraHNakanumaSHayashiHTajimaHKakinokiKKitaharaMSakaiSMakinoINakagawaraHMiyashitaTSevere veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantationTransplant Proc4635233535201410.1016/j.transproceed.2014.09.11025498084 PaiRKvan BesienKHartJArtzASO'DonnellPHClinicopathologic features of late onset veno-occlusive disease/sinusoidal obstructive syndrome after high dose busulfan and hematopoietic cell transplantationLeuk Lymphoma5315521557201210.3109/10428194.2012.661052222805174482341 CarrerasEGrañenaARozmanCHepatic veno-occlusive disease after bone marrow transplantBlood Rev74351199310.1016/0268-960X(93)90023-W8467232 BattinelliEMMarkensBAItalianoJEJrRelease of angiogenesis regulatory proteins from platelet alpha granules: Modulation of physiologic and pathologic angiogenesisBlood11813591368201110.1182/blood-2011-02-334524216808003152500 CuiSShibamotoTLiuWTakanoHKurataYEffects of platelet- activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liverProstaglandins Other Lipid Mediat803545200610.1016/j.prostaglandins.2006.03.00416846785 NarmadaBCChiaSMTucker-KelloggLYuHHGF regulates the activation on TGF-β1 in rat hepatocytes and hepatic stellate cellsJ Cell Physiol228393401201310.1002/jcp.2414322718393 ParentiABrogelliLFilippiSDonniniSLeddaFEffect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: Role of fit-1/VEGF-receptor-1Cardiovasc Res55201212200210.1016/S0008-6363(02)00326-712062723 OatesJAFitzGeraldGABranchRAJacksonEKKnappHRRobertsLJIIClinical implications of prostaglandin and thromboxane A2 formation (1)N Eng J Med319689698198810.1056/NEJM198809223191206 AttalMHuguetFRubieHHuynhACharletJPPayenJLVoigtJJBroussetPSelvesJMullerCPrevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trialBlood792834284019921586733

Macroscopic findings in (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. The latter showed accumulation of bloody ascites. In addition, the liver surface was dark red in color.

H&E staining of (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. The latter showed congestion and destruction of hepatocytes around the central vein (zone 3).

Immunohistochemical staining with antibody to CD41 of (A) the normal liver of a control rat, and (B) the liver of a rat with MCT-induced SOS. The latter showed staining for CD41 around the central vein, whereas the former showed no staining.

Immunohistochemical staining with antibody to P-selectin of (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. In control rats, only liver sinusoidal endothelial cells (LSECs) were positive for P-selectin. In MCT treated rats, LSECs and platelets were stained.

Immunohistochemical staining with antibody to RECA-1 of (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. Normal rat endothelial cells were strongly positive for RECA-1, whereas MCT-treated animals were weakly positive.

Immunohistochemical staining with antibody to CD34 of (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. CD34 expression was higher in MCT-treated rats, especially in zone 3, than in control rats.

Immunohistochemical staining with antibody to caspase-3 of (A) the normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. Normal rat liver was negative for caspase-3, whereas MCT-treated rats showed caspase-3 staining of hepatocytes around the central vein.

Electron microscopic findings of the liver of a rat with MCT-induced SOS. (A) Presence of neutrophils and red blood cells in the sinusoidal space. (B) Many platelets containing granules (white arrows) were present in the space of Disse (white square in A).

Blood counts and serum biochemistry.

Variables MCT group (n=10) Control group (n=10) P-value
Hb (g/dl) 14.73±1.43 14.34±1.04 0.281
WBC (x103/µl) 48.6±17.8 73.6±11.1 0.232
Plt (x103/µl) 5.87±2.7 75.78±8.3 0.004
AST (IU/l) 7,218.0±4071.3 82.9±9.1 0.003
ALT (IU/l) 1,539.2±837.7 33.4±5.4 0.008
T-Bil (mg/dl) 0.211±0.083 0.038±0.007 0.012
D-Bil (mg/dl) 0.126±0.053 0.032±0.004 0.007
I-Bil (mg/dl) 0.085±0.038 0.006±0.005 0.003
LDH (mg/dl) 5,664.9±3,700.9 312.9±158.7 <0.001
HA (ng/dl) 1,188.3±729.0 36.8±3.9 0.016

Hb, hemoglobin; WBC, white blood cell; Plt, platelet; AST, spartate aminotransferase; ALT, alanine aminotransferase; T-Bil, total bilirubin; D-Bil, direct bilirubin; I-Bil, indirect bilirubin; LDH, lactate dehydrogenase; HA, hyaluronic acid.

Expression areas of immunohistochemical examination

Variables MCT group (µm2) Control group (µm2) P-value
CD41 2,405.0±2,476.3 760.0±11.8 0.014
P-selectin 14,653.7±2,324.0 11,678.1±505.0 0.034
RECA-1 51,503.0±174.0 246,664.0±64,171.0 0.001
CD34 113,914±5,336 18,720±4,780 <0.001
Cleaved 974±335 8.3±0.7 0.003
Caspase-3

RECA-1, rat endothelial cell antigen-1.